Stocksigma LogoStocksigma Logo

Rossari Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 6,976 (+19.0% YoY | +0.1% QoQ) ■ EBITDA: 870 (+20.9% YoY | +7.9% QoQ) ■ EBITDA Margin (%): 12.5 (+20 bps YoY | +90 bps QoQ) ■ PAT: 389 (+5.5%

Rossari Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Rossari Biotech Ltd · Outcome · 18 Oct 2026, 12:41 am

Rossari Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 6,976 (+19.0% YoY | +0.1% QoQ) ■ EBITDA: 870 (+20.9% YoY | +7.9% QoQ) ■ EBITDA Margin (%): 12.5 (+20 bps YoY | +90 bps QoQ) ■ PAT: 389 (+5.5% YoY | +10.9% QoQ) ■ EPS (INR): 7.02 (+5.6% YoY | +10.9% QoQ)

Original exchange filing (PDF)

More announcements from Rossari Biotech Ltd

All Rossari Biotech Ltd announcements